Accès libre Évalué par les pairs

Articles · Vol. 18 No 2 (2014): Revue africaine de sociologie · Pages 42 - 60

Essential Medicines in Nigeria: Foregrounding Access to Affordable Essential Medicines

  • Chinwe Obuaku
    Chinwe Obuaku Research in Anthropology and Sociology of Health (RASH) Department of Anthropology and Sociology University of the Western Cape, Cape Town, South Africa https://orcid.org/0000-0001-7529-6924 (non authentifié)
    Dr CC Obuaku-Igwe is a Lecturer in the Department of Sociology. She teaches at both UG and PG levels anchoring the department’s sociology of health, career counselling and mentoring at undergraduate level. Other courses in her teaching portfolio include, Research methods, and...
    Ses articles →
Vol. 18 · 2014 N°2 Revue africaine de sociologie ASR

Résumé

Au sein de chaque système de santé fonctionnel, l’accès aux médicaments essentiels de qualité et à prix abordable se distingue comme l’un des blocs de construction . Cependant , son importance a
été sous-estimé en raison de la mauvaise sensibilisation et de recherche . L’implication est que l’accès à la qualité et aux médicaments essentiels abordables demeure un défi pour de nombreuses personnes dans les pays à faible revenu / moyennes et pourrait créer des difficultés dans la tentative de réformer les systèmes de soins de santé et sauver des vies si pas donné une grande attention . Cet article présente une enquête sur le système de santé du Nigeria avec un accent particulier sur l’accès aux médicaments essentiels en tant que composante du système de soins de santé du N tilisant la méthode de recherche qualitative .

Essential Medicines in Nigeria: Foregrounding Access to Affordable Essential Medicines

Within every functional healthcare system, access to quality and affordable essential medicine stands out as one of the building blocks. However, its significance has been underrated due to poor advocacy and research. The implication is that access to quality and affordable essential medicines remains a challenge to many people in low / middle income countries and could create difficulty in the attempt to reform healthcare systems and save lives if not given ample attention. This paper presents a critical discussion of the Nigerian health system with special focus on access to essential medicines as a component of the Nigerian healthcare system by drawing upon primary data, using qualitative research method.

Mots-clés

Accès aux médicaments les médicaments essentiels la santé les établissements de santé publics les systèmes de santé

Statistiques

Consultations du résumé
1 333
Téléchargements
86

Citations

0 citations

Google Scholar

Citations recensées par OpenAlex, base ouverte de la littérature scientifique, mise à jour chaque semaine. Google Scholar peut en compter davantage.

Biographie de l'auteur/ice

  • Chinwe Obuaku, Research in Anthropology and Sociology of Health (RASH) Department of Anthropology and Sociology University of the Western Cape, Cape Town, South Africa

    Dr CC Obuaku-Igwe is a Lecturer in the Department of Sociology. She teaches at both UG and PG levels anchoring the department’s sociology of health, career counselling and mentoring at undergraduate level. Other courses in her teaching portfolio include, Research methods, and Advanced Social theory at postgraduate level. She is the founder of IndimaYethu mentoring program and currently on the editorial board of First Thinking review. As a sociologist, her overarching research interest is in the field of sociology of health and development with focus on Health policy and health systems.She has published on access to quality and affordable essential medicines in Nigeria and inequalities in healthcare in South Africa. Her Research explicates health and capacity development in Africa, focusing on economic growth, political and social change. Chinwe has published with African Sociological Review, a publication of CODESRIA (Council for the Development of Social Science Research in Africa).

Références

  1. Atun R. (2012). Health systems, systems thinking and innovation. Health Policy and Planning 2012; 27:iv4-8.
  2. Adam T, Hsu J, de Savigny D, (2012). Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions? Health Policy and Planning 2012; 27:iv9-19.
  3. Bodeker G, Kronenberg F (2002) “A public health agenda for traditional, complementary, and alternative medicine,” American Journal of Public Health, vol. 92, no. 10, pp. 1582–1591, 2002.
  4. Butler C (2007). “Human Rights and the World Trade Organization: The Right to Essential Medicines and the TRIPS Agreement”. Journal of International Law & Policy 5: 1–27.
  5. Cameron A, Ewen M, Ross-Degnan D (2009). Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 373: 240–9.
  6. Collins D, Oakey S, Ramakrishnan V.(2011) Perioperative use of herbal, complementary and over the counter medicines in plastic surgery patients. Eplasty 2011, 11:e27 Ezeome E, Anarado A (2012). Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria
  7. Federal Ministry of Health (2002) Baseline assessment of the Nigerian pharmaceutical Sector, a publication of the Federal Ministry of Health in collaboration with the World Health Organization
  8. Federal Ministry of health (2003) Situation of Antiretroviral Drug Use in Nigeria.
  9. Federal Ministry of Health in collaboration with WHO, November 2003 Federal Ministry of Health. (2004) Medicines Price Survey - the prices people pay for their
  10. medicines in Nigeria. Federal Ministry of Health in Nigeria and sponsored by the World Health Organization -WHO and Health Action International –HAI.
  11. Federal ministry of health (2006a) Baseline Assessment of the price people pay for Medicines in Nigeria. A publication of the Federal Ministry of Health in collaboration with the World Health Organization, DFID and HAI.
  12. Federal ministry of health (2006b) Baseline Assessment of the Nigerian Pharmaceutical Sector. A publication of the Federal Ministry of Health in collaboration with the World Health Organization, DFID and HAI.
  13. Fakeye T, Adisa R, Musa E (2009). Attitude and use of herbal medicines among pregnant women in Nigeria. BMC Complement Altern Med. 2009;9:53. doi: 10.1186/1472-6882-9-53
  14. Francis K, (2013) “Unlike India, China not helping Nigeria stop fake drugs’,” New York Daily News, May 15, 2013
  15. Gharoro E, Igbafe A (2000). Pattern of drug use amongst antenatal patients in Benin City, Nigeria. Med Sci Monit. 2000 Jan-Feb;6(1):84-7
  16. Goddard M, Smith P Soc Sci Med. 2001. Equity of access to health care services: theory and evidence from the UK. Centre for Health Economics, University of York, Heslington, UK Nov;53(9):1149-62
  17. Helwig D (2010). Traditional African Medicine. Encyclopedia of Alternative Medicine.
  18. http://findarticles.com/ p/articles/mi_g2603/is_0007/ai_2603000708/.
  19. Holloway K, Van D (2011). Rational Use of Medicines. The World Medicines Situation 2011. Geneva, Switzerland: World Health Organization
  20. Jacobs B, Ir P, Bigdeli M, Annear P, Van D (2012). Addressing access barriers to health services for the poor: an analytical framework for selecting appropriate interventions in low income countries. Health Policy and Planning 27: 288–300. Kotwani A. (2009). Availability, price and affordability of asthma medicines in five Indian states. The International Journal of Tuberculosis and Lung Disease 13: 574–9.
  21. Ransome O,(1992) “National Drug Policy in Nigeria”. Journal of Public Health Policy > Vol. 13, No. 3 (autumn, 1992), pp. 367-373
  22. Nwako S, Fakeye T. (2010). Evaluation of use of herbal medicines among ambulatory hypertensive patients attending a secondary health care facility in Nigeria
  23. Obi E, Akunyili D, Ekpo B, Orisakwe O (2006) Heavy metal hazards of Nigerian herbal remedies. Sci Total Environ 2006, 369:35-41
  24. Oshikoya K, Senbanjo O, Njokanma F, Soipe A (2008). Use of complementary and alternative medicines for children with chronic health conditions in Lagos Nigeria. http://www.ncbi.nlm.nih.gov/pubmed/19113999
  25. Ogunleye A, Adeyeye O, Onadeko O, Bamisile T, Olubusi A (2011). The use of complementary and alternative medicine by asthma patients receiving care in an urban tertiary centre in Nigeria. : http://www.biomedscidirthe_use_of_complementary_and_alternative_medicine_by_asthma_patients_receiving_ care_in_an_urban_tertiary_centre_in_nigeria&ei=Penchansky R, Williams T (1981). The concept of access: definition and relationship to consumer satisfaction. Medical Care 19: 127–40.
  26. Quick J, Hogerzeil H (2002). Perspectives: twenty-five years of essential medicines. Bulletin of the World Health Organization 80: 913–4.
  27. Rais A (1991) “Health Care Patterns and Planning in Developing Countries” Greenwood Press, 1991. pp 264
  28. Ronald J. (1993) Financing Health Care in Sub-Saharan Africa Greenwood Press, 1993. Pp 9 - 18
  29. Stanley B (2004). Recognition and Respect for African Traditional Medicine, Canada’s International Development Research Centre., http://www.idrc.ca/EN/Resources/Publications/Pages/ArticleDetails.aspx?PublicationID=713
  30. Shankar PR. (2009). Medicines Use in Primary Care in Developing and Transitional Countries: Fact
  31. Book Summarizing Results from Studies Reported between 1990 and 2006. Geneva, Switzerland: World Health Organization
  32. Tamuno A, Fadare J (2010) Use of Herbal Medicine Among Pregnant Women Attending A Tertiary Hospital
  33. In Northern Nigeria. The Internet Journal of Gynecology and Obstetrics. 2010 Vol. 15 No. 2
  34. Tonia C, Humphrey A, Ogochukwu M, Emeka A, Elias C, Samson U, Timothy E (2012). Herbal medicine: a survey of use in Nigerian presurgical patients booked for ambulatory anaesthesia. BMC Complementary and Alternative Medicine 12:130 doi: 10.1186/1472-6882-12-130 http://www.biomedcentral.com/1472-6882/12/130
  35. Tinde V, Luísa C,(2013) “Why Urban Citizens in Developing Countries Use Traditional Medicines: The Case of Suriname,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 687197, 13 pages, 2013. doi:10.1155/2013/687197
  36. World Health Organization (2000a) world medicines strategy: framework for action in essential drugs and medicines policy 2000–2003. Geneva, World Health Organization, 2000.
  37. The World Health Report. (2000b). Health systems: improving performance. Geneva, World Health Organization, 2000.
  38. World Health Organization. (2000c). Promoting the Role of Traditional Medicine in Health Systems: a Strategy for the African Region 2001–2010. Harare: World Health Organization; 2000. Document reference AFR/RC50/Doc.9/R.
  39. World Health Organization. (2000d) Traditional and Modern Medicine: Harmonising the two approaches- Western Pacific Region. Geneva: World Health Organisation; 2000.
  40. World Health Organization,(2000e). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Geneva: World Health Organisation; 2000.
  41. World Health Organization.(2004). “The world medicines situation” .pp61-74. Geneva, WHO
  42. World Health Organization. (2005). “National policy on Traditional Medicine and Regulation of Herbal Medicines”: Report of a WHO global survey, Geneva. pp 68, may 2005
  43. World Health Organization. (2006). Quality of care: a process for making strategic choices in health systems. World Health Organization, France
  44. World Health Organization (2008). Traditional Medicine Fact sheet
  45. World Health Organization (2010). Key components of a well-functioning health system. World Health Organization. Geneva.
  46. World Health Organization (2013). Global Health Observatory Data Repository. WHO, Geneva.

Dans le même numéro

Vol. 18 No 2 (2014): Revue africaine de sociologie →